SCHEMBL30689442

SCHEMBL30689442

C=C(Cc1nc(-c2ncc(Oc3ccc(F)cn3)cc2Cl)no1)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ GSTP1 P09211 6/20 0.41
▸ CNR2 P34972 5/20 0.35
▸ CNR1 P21554 3/20 0.35
▸ GABRA5 P31644 1/20 0.34
▸ PPARG P37231 1/20 0.34
▸ SCN9A Q15858 2/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ FFAR1 O14842 1/20 0.34
▸ FPR2 P25090 1/20 0.34
▸ HCAR2 Q8TDS4 1/20 0.34
▸ SCN7A Q01118 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ MLNR O43193 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27291640 0.90 GSTP1 (0.47) GSTP1CNR2CNR1PPARGKMT2A
SCHEMBL30689397 0.82 AKR1B1 (0.39) GSTP1CNR2CNR1PPARGSCN9A
SCHEMBL30689377 0.82 GSTP1 (0.38) GSTP1CNR2CNR1PPARGKMT2A
SCHEMBL27291563 0.78 GSTP1 (0.41) GSTP1CNR2CNR1FFAR1
SCHEMBL27291637 0.78 GSTP1 (0.45) GSTP1CNR2CNR1PPARGSCN9A
SCHEMBL30689313 0.74 CNR2 (0.40) GSTP1CNR2CNR1FFAR1
SCHEMBL30689438 0.74 LMNA (0.51) GSTP1
SCHEMBL31527956 0.73 GSTP1 (0.43) GSTP1CNR2CNR1PPARGFFAR1
SCHEMBL30689303 0.72 TP53 (0.42) GSTP1KMT2AFFAR1
SCHEMBL30689302 0.72 FFAR1 (0.49) GSTP1SCN9AFFAR1FPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4543875-A1 OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES Sitryx Therapeutics Limited (GB) 2025-04-30 — — EP disclosed
WO-2023247958-A1 OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES SITRYX THERAPEUTICS LIMITED (GB) 2023-12-28 — — WO disclosed
Send feedback